Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 97-77-8
Drug Levels and Effects
Summary of Use during Lactation
Because no information is available on the use of disulfiram during breastfeeding, an alternate drug is preferred, especially while nursing a newborn or preterm infant. Drug labeling recommends that disulfiram not be given to nursing mothers.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Disulfiram
CAS Registry Number
97-77-8
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- A method for the determination of tetraethylthiuram disulphide (Antabus, Abstinyl) and diethyldithiocarbamate in blood and urine; some studies on the metabolism of tetraethylthiuram disulphide.[Scand J Clin Lab Invest. 1951]A method for the determination of tetraethylthiuram disulphide (Antabus, Abstinyl) and diethyldithiocarbamate in blood and urine; some studies on the metabolism of tetraethylthiuram disulphide.LINDERHOLM H, BERG K. Scand J Clin Lab Invest. 1951; 3(2):96-102.
- The use of antabus in the therapy of alcoholic patients.[Calif Med. 1950]The use of antabus in the therapy of alcoholic patients.MORIARTY JD. Calif Med. 1950 Aug; 73(2):144-7.
- Formation of an S-glucuronide from tetraethylthiuram disulfide (Antabuse) in man.[Biochim Biophys Acta. 1963]Formation of an S-glucuronide from tetraethylthiuram disulfide (Antabuse) in man.KASLANDER J. Biochim Biophys Acta. 1963 Jun 4; 71:730-1.
- Review Disulfiram (tetraethylthioperoxydicarbonic diamide): a reappraisal of its toxicity and therapeutic application.[Drug Metab Rev. 1979]Review Disulfiram (tetraethylthioperoxydicarbonic diamide): a reappraisal of its toxicity and therapeutic application.Haley TJ. Drug Metab Rev. 1979; 9(2):319-35.
- Review Flunarizine.[Drugs and Lactation Database (...]Review Flunarizine.. Drugs and Lactation Database (LactMed®). 2006
- Disulfiram - Drugs and Lactation Database (LactMed®)Disulfiram - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...